AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 95 filers reported holding AKERO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $21,214,769 | +54.2% | 419,430 | +42.3% | 0.01% | +50.0% |
Q2 2023 | $13,757,769 | +50.9% | 294,662 | +23.6% | 0.00% | +33.3% |
Q1 2023 | $9,119,156 | -29.7% | 238,347 | +0.7% | 0.00% | -25.0% |
Q4 2022 | $12,965,516 | +78.7% | 236,597 | +11.1% | 0.00% | +33.3% |
Q3 2022 | $7,254,000 | +365.6% | 213,019 | +29.2% | 0.00% | +200.0% |
Q2 2022 | $1,558,000 | -36.7% | 164,823 | -5.0% | 0.00% | 0.0% |
Q1 2022 | $2,463,000 | -33.2% | 173,546 | -0.4% | 0.00% | 0.0% |
Q4 2021 | $3,686,000 | -0.3% | 174,252 | +5.4% | 0.00% | 0.0% |
Q3 2021 | $3,696,000 | +7.2% | 165,353 | +19.0% | 0.00% | 0.0% |
Q2 2021 | $3,449,000 | +7.0% | 138,993 | +25.1% | 0.00% | 0.0% |
Q1 2021 | $3,224,000 | +15.8% | 111,111 | +2.9% | 0.00% | 0.0% |
Q4 2020 | $2,785,000 | -16.1% | 107,932 | +0.1% | 0.00% | -50.0% |
Q3 2020 | $3,320,000 | +161.4% | 107,813 | +111.6% | 0.00% | +100.0% |
Q2 2020 | $1,270,000 | +35.1% | 50,945 | +14.9% | 0.00% | 0.0% |
Q1 2020 | $940,000 | +16.9% | 44,326 | +22.4% | 0.00% | – |
Q4 2019 | $804,000 | +9.4% | 36,224 | +12.2% | 0.00% | – |
Q3 2019 | $735,000 | – | 32,289 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ATP Life Science Ventures, L.P. | 5,830,203 | $179,512,000 | 24.20% |
venBio Partners LLC | 2,444,311 | $75,260,000 | 11.44% |
Versant Venture Management, LLC | 777,727 | $23,946,000 | 4.38% |
Redmile Group, LLC | 2,336,357 | $71,936,000 | 1.32% |
Vivo Capital, LLC | 571,833 | $17,607,000 | 1.02% |
Cormorant Asset Management, LP | 859,550 | $26,466,000 | 1.02% |
Boxer Capital, LLC | 831,495 | $25,602,000 | 0.88% |
Integral Health Asset Management, LLC | 85,000 | $2,617,000 | 0.80% |
EAM Global Investors LLC | 49,718 | $1,531,000 | 0.56% |
Crawford Lake Capital Management, LLC | 43,826 | $1,349,000 | 0.56% |